Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response from PTSC IR on Shareholders meeting

<They want to put a dividend strategy to the vote in the Proxy - but have to await a certain negotiation outcome.>

Actually that does make sense to me You wouldn't want to put the cart before the horse.

Opty


Share
New Message
Please login to post a reply